TERT and cholangiocarcinoma: We evaluated the frequency of TERT promoter and CTNNB1 mutations in 146 hepatocellular nodules including HCAs, LRNs, LDNs, HDNs, HCCs, and combined HCCs and cholangiocarcinomas.